510(k) Report

510(k) · Cleared

Cleared

Cove Putty, OsteoCove Putty

K231030510(k) TraditionalCleared Sep 14, 2023156-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

SeaSpine Orthopedics Corporation · MQV Filler, Bone Void, Calcium Compound

Cleared on Sep 14, 2023 as substantially equivalent to K140375 (Medtronic Sofamor Danek USA, Inc., 2014) and 2 other predicates after a 156-day review. Its family tree reaches back 9 generations to 1996.

Decided
Sep 14, 2023
Review
156 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
3

Its longest line of descent runs back 9 generations to K960978 (1996). 45 ancestors in all, the oldest K871773 (1987). No later device cites it as a predicate yet.

  1. Root · 9 generations backK960978 Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc · 1996
  2. 5 generations between
  3. 3 generations backK071813 Mastergraft PuttyMedtronic Sofamor Danek · 2007
  4. 2 generations backK082166 Mastergraft StripMedtronic Sofamor Danek · 2009
  5. 1 generation backK140375 Mastergraft Putty, Mastergraft StripMedtronic Sofamor Danek USA, Inc. · 2014
  6. This deviceK231030 Cove Putty, OsteoCove PuttySeaSpine Orthopedics Corporation · 2023
Show all 9 generations
  1. Root · 9 generations backK960978 Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc · 1996
  2. 8 generations backK980817 Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model…Interpore Intl. · 1998
  3. 7 generations backK000515 Pro Osteon 200R Resorbable Bone Graft Substitute, Models 2RG051…Interpore Cross Intl. · 2000
  4. 6 generations backK012751 Healos Bone Graft MaterialOrquest, Inc. · 2001
  5. 5 generations backK043308 Modification to: Healos Bone Graft MaterialDepuy Spine, Inc. · 2005
  6. 4 generations backK051386 Mastergraft Putty Bone Void FillerMedtronic Vascular · 2005
  7. 3 generations backK071813 Mastergraft PuttyMedtronic Sofamor Danek · 2007
  8. 2 generations backK082166 Mastergraft StripMedtronic Sofamor Danek · 2009
  9. 1 generation backK140375 Mastergraft Putty, Mastergraft StripMedtronic Sofamor Danek USA, Inc. · 2014
  10. This deviceK231030 Cove Putty, OsteoCove PuttySeaSpine Orthopedics Corporation · 2023
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−9K960978Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc1996—
−8K980817Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05…Interpore Intl.1998—
−7K000515Pro Osteon 200R Resorbable Bone Graft Substitute, Models 2RG051, 2RG101…Interpore Cross Intl.2000—
−6K012751Healos Bone Graft MaterialOrquest, Inc.2001—
−5K043308Modification to: Healos Bone Graft MaterialDepuy Spine, Inc.2005—
−4K051386Mastergraft Putty Bone Void FillerMedtronic Vascular2005—
−3K071813Mastergraft PuttyMedtronic Sofamor Danek2007—
−2K082166Mastergraft StripMedtronic Sofamor Danek2009—
−1K140375Mastergraft Putty, Mastergraft StripMedtronic Sofamor Danek USA, Inc.2014—
0 (this device)K231030Cove Putty, OsteoCove PuttySeaSpine Orthopedics Corporation2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198710
199210
199520
199710
199820
199910
200020
200120
200230
200330
200430
200570
200630
200730
200910
202110
FIG. 1 — Lineage of K231030, 1996–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K140375Mastergraft Putty, Mastergraft Strip
Summary page 5
…Trade Name Manufacturer Primary Predicate Device Medtronic Sofamor K140375 MQV MASTERGRAFT Putty Danek US…
Medtronic Sofamor Danek USA, Inc.2014—
*K062353Mozaik Bone Regeneration Matrix - Putty
Summary page 5
…Danek USA, Inc. Additional Predicate Devices Integra MOZAIKTM Bone Integra LifeSciences K062353 MQV Regeneration Matrix – Putty* Corporation…
Integra LifeSciences Corporation20063
*K212135Dry DBM- A Putty
Summary page 5
…Regeneration Matrix – Putty* Corporation IsoTis OrthoBiologics, K212135 MQV, MBP Torrent/Torrent C**…
Seaspine Corporation2021—

Also cleared against K140375: 16 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 27 years and passes through 9 companies; a new generation was cleared every 2.0 years on median.
  • 8 of the 45 ancestors have a recall of any class.
  • 16 other devices also cite its predicate K140375.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

Cove Putty is intended to fill voids and gaps in the skeletal system that are not intrinsic to the stability of the bony structure. The product is indicated for use with autograft as a bone graft extender in the posterolateral spine and pelvis. The voids or gaps may be surgically created defects or the result of traumatic injury to the bone. Cove Putty is hydrated with saline at the point-of-use. OsteoCove Putty is intended to fill voids and gaps in the…

Read the full statement (140 words)

Cove Putty is intended to fill voids and gaps in the skeletal system that are not intrinsic to the stability of the bony structure. The product is indicated for use with autograft as a bone graft extender in the posterolateral spine and pelvis. The voids or gaps may be surgically created defects or the result of traumatic injury to the bone. Cove Putty is hydrated with saline at the point-of-use.

OsteoCove Putty is intended to fill voids and gaps in the skeletal system that are not intrinsic to the stability of the bony structure. The product is indicated for use with autograft as a bone graft extender in the posterolateral spine and pelvis. The voids or gaps may be surgically created defects or the result of traumatic injury to the bone. OsteoCove Putty is hydrated with saline at the point-of-use.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K231030: Cove Putty, OsteoCove Putty.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K231030

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026